Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol

Journal of Steroid Biochemistry and Molecular Biology

Volumn 87, Issue 1, 2003, Pages 65-73

  Paquette, Benoit ^a   Bisson, Martine ^a   Therriault, Hélène ^a   Lemay, Rosalie ^a   Paré, Mélanie ^a   Banville, Pascale ^a   Cantin, André M ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Estrogens; Free radicals; Matrix metalloproteinase; Metastasis

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRADIOL; 2 METHOXYESTRADIOL; 4 HYDROXYESTRADIOL; 4 METHOXYESTRADIOL; ESTRADIOL; ESTRONE; FREE RADICAL; GELATINASE A; GELATINASE B; HYDROXYL RADICAL; SUPEROXIDE;

ARTICLE; BREAST CANCER; CANCER INVASION; ENZYME ACTIVATION; PROTEIN DEGRADATION; ZYMOGRAPHY;

EID: 0242712310     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00386-8     Document Type: Article

References (42)

1. DeClerck Y.A., Imren S., Montgomery A.M., Mueller B.M., Reisfeld R.A., Laug W.E. Proteases and protease inhibitors in tumour progression. Adv. Exp. Med. Biol. 425:1997;89-97.
2. Murphy G., Docherty A.J. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell. Mol. Biol. 7(2):1992;120-125.
3. Balduyck M., Zerimech F., Gouyer V., Lemaire R., Hemon B., Grard G., Thiebaut C., Lemaire V., Dacquembronne E., Duhem T., Lebrun A., Dejonghe M.J., Huet G. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin. Exp. Metastasis. 18(2):2000;171-178.
4. Garbett E.A., Reed M.W., Brown N.J. Proteolysis in human breast and colorectal cancer. Br. J. Cancer. 81(2):1999;287-293.
5. 2 exposure. Lab. Invest. 77(5):1997;533-539.
6. Liotta L.A., Stetler-Stevenson W.G. Tumour invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51(Suppl. 18):1991;5054s-5059s.
7. Springman E.B., Angleton E.L., Birkedal-Hansen H., Van Wart H.E. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. U.S.A. 87(1):1990;364-368.
8. Van Wart H.E., Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87(14):1990;5578-5582.
9. Shaughnessy S.G., Whaley M., Lafrenie R.M., Orr F.W. Walker 256 tumour cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch. Biochem. Biophys. 304(2):1993;314-321.
10. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J. Clin. Invest. 98(11):1996;2572-2579.
11. Saari H., Suomalainen K., Lindy O., Konttinen Y.T., Sorsa T. Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem. Biophys. Res. Commun. 171(3):1990;979-987.
12. Abul-Hajj Y.J., Thijssen J.H., Blankenstein M.A. Metabolism of estradiol by human breast cancer. Eur. J. Cancer Clin. Oncol. 24(7):1988;1171-1178.
13. Liehr J.G., Ricci M.J. 4-Hydroxylation of estrogens as marker of human mammary tumours. Proc. Natl. Acad. Sci. U.S.A. 93(8):1996;3294-3296.
14. McKay J.A., Melvin W.T., Ah-See A.K., Ewen S.W., Greenlee W.F., Marcus C.B., Burke M.D., Murray G.I. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett. 374(2):1995;270-272.
15. Fishman J., Schneider J., Hershcope R.J., Bradlow H.L. Increased estrogen-16α-hydroxylase activity in women with breast and endometrial cancer. J. Steroid Biochem. 20(4B):1984;1077-1081.
16. Muti P., Bradlow H.L., Micheli A., Krogh V., Freudenheim J.L., Schunemann H.J., Stanulla M., Yang J., Sepkovic D.W., Trevisan M., Berrino F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16 α-hydroxyestrone ratio in pre- and post-menopausal women (in process citation). Epidemiology. 11(6):2000;635-640.
17. Thibodeau P.A., Paquette B. DNA damage induced by catecholestrogens in the presence of copper. Part II: Generation of reactive oxygen species and enhancement by NADH. Free Radic. Biol. Med. 27(11-12):1999;1367-1377.
18. Li Y., Trush M.A., Yager J.D. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis. 15(7):1994;1421-1427.
19. Liehr J.G., Roy D. Free radical generation by redox cycling of estrogens. Free Radic. Biol. Med. 8(4):1990;415-423.
20. Buettner G.R. Use of ascorbate as test for catalytic metals in simple buffers. Methods Enzymol. 186:1990;125-127.
21. Albini A., D'Agostini F., Giunciuglio D., Paglieri I., Balansky R., De Flora S. Inhibition of invasion, gelatinase activity, tumour take and metastasis of malignant cells by N-acetylcysteine. Int. J. Cancer. 61(1):1995;121-129.
22. Thibodeau P., Kachadourian R., Lemay R., Bisson M., Day B., Paquette B. In vitro pro- and antioxidant properties of estrogens. J. Steroid Biochem. Mol. Biol. 81(3):2002;227.
23. Li Y., Trush M.A. Oxidation of hydroquinone by copper: chemical mechanism and biological effects. Arch. Biochem. Biophys. 300(1):1993;346-355.
24. Itoh Y., Binner S., Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem. J. 308(Pt. 2):1995;645-651.
25. Greenspan F.S., Baxter D.B. Basic & Clinical Endocrinology, A Lange Medical Book, fourth ed., Appleton & Lange, Connecticut, 1994.
26. Jefcoate C.R., Liehr J.G., Santen R.J., Sutter T.R., Yager J.D., Yue W., Santner S.J., Tekmal R., Demers L., Pauley R., Naftolin F., Mor G., Berstein L. Tissue-specific synthesis and oxidative metabolism of estrogens. J. Natl. Cancer Inst. Monogr. 27:2000;95-112.
27. Rochefort H., Platet N., Hayashido Y., Derocq D., Lucas A., Cunat S., Garcia M. Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J. Steroid Biochem. Mol. Biol. 65(1-6):1998;163-168.
28. van den Brule F.A., Engel J., Stetler-Stevenson W.G., Liu F.T., Sobel M.E., Castronovo V. Genes involved in tumour invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int. J. Cancer. 52(4):1992;653-657.
29. Abbas Abidi S.M., Howard E.W., Dmytryk J.J., Pento J.T. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells. Clin. Exp. Metastasis. 15(4):1997;432-439.
30. Hayashido Y., Lucas A., Rougeot C., Godyna S., Argraves W.S., Rochefort H. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int. J. Cancer. 75(4):1998;654-658.
31. Berstein L.M., Larionov A.A., Kyshtoobaeva A., Pozharisski K.M., Semiglazov V.F., Ivanova O.A. Aromatase in breast cancer tissue - localization and relationship with reproductive status of patients. J. Cancer Res. Clin. Oncol. 122(8):1996;495-498.
32. Esteban J.M., Warsi Z., Haniu M., Hall P., Shively J.E., Chen S. Detection of intratumoural aromatase in breast carcinomas: an immunohistochemical study with clinicopathologic correlation. Am. J. Pathol. 140(2):1992;337-343.
33. Santen R.J., Martel J., Hoagland M., Naftolin F., Roa L., Harada N., Hafer L., Zaino R., Santner S.J. Stromal spindle cells contain aromatase in human breast tumours. J. Clin. Endocrinol. Metab. 79(2):1994;627-632.
34. Reed M.J., Owen A.M., Lai L.C., Coldham N.G., Ghilchik M.W., Shaikh N.A., James V.H. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. Int. J. Cancer. 44(2):1989;233-237.
35. Castagnetta L.A., Granata O.M., Traina A., Ravazzolo B., Amoroso M., Miele M., Bellavia V., Agostara B., Carruba G. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin. Cancer Res. 8(10):2002;3146-3155.
36. Margalioth E.J., Schenker J.G., Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer. 52(5):1983;868-872.
37. Kumaraguruparan R., Subapriya R., Viswanathan P., Nagini S. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin. Chim. Acta. 325(1-2):2002;165-170.
38. Polat M.F., Taysi S., Gul M., Cikman O., Yilmaz I., Bakan E., Erdogan F. Oxidant-antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem. Funct. 20(4):2002;327-331.
39. Thibodeau P.A., Kocsis-Bedard S., Courteau J., Niyonsenga T., Paquette B. Thiols can either enhance or suppress DNA damage induction by catecholestrogens. Free Radic. Biol. Med. 30(1):2001;62-73.
40. Lesperance M.L., Olivotto I.A., Forde N., Zhao Y., Speers C., Foster H., Tsao M., MacPherson N., Hoffer A. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res. Treat. 76(2):2002;137-143.
41. Tagliaferri M., Cohen I., Tripathy D. Complementary and alternative medicine in early-stage breast cancer. Semin. Oncol. 28(1):2001;121-134.
42. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342(2):1997;261-274.